Cargando…

Development of pre-clinical and clinical models to predict the efficacy and safety of vaginal microbicides

Detalles Bibliográficos
Autor principal:	Herold, Betsy C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716964/ http://dx.doi.org/10.1186/1742-4690-3-S1-S53

Ejemplares similares

Development of a live topical microbicide for women
por: Xu, Qiang, et al.
Publicado: (2006)

Microbicide development: multiple targets, multiple mechanisms
por: Shattock, Robin
Publicado: (2006)

Live microbial microbicides for HIV
por: Hamer, Dean, et al.
Publicado: (2006)

Multiple dosage forms of the NNRTI microbicide dapivirine: product development and evaluation
por: Romano, Joseph
Publicado: (2006)

Bridging the Gap between Preclinical and Clinical Microbicide Trials: Blind Evaluation of Candidate Gels in Murine Models of Efficacy and Safety
por: Segarra, Theodore J., et al.
Publicado: (2011)

Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission
por: Moore, John P
Publicado: (2006)

Recepta biopharma portfolio: clinical and pre clinical development
por: Tuma, M Carolina
Publicado: (2014)

Development of a CCR5-tropic HIV-1 fusion inhibition assay amenable to high-throughput screening for topical microbicides
por: Beer, B, et al.
Publicado: (2006)

Highly potent, fully recombinant RANTES analogues represent promising new candidate microbicides
por: Hartley, Oliver
Publicado: (2006)

The Development of Vaginal Microbicides for the Prevention of HIV Transmission
por: Weber, Jonathan, et al.
Publicado: (2005)

PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
por: Burgos-Vargas, R, et al.
Publicado: (2013)

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials
por: Mâsse, Benoît R, et al.
Publicado: (2009)

Safety and efficacy of G2-S16 dendrimer as microbicide in healthy human vaginal tissue explants
por: Rodríguez-Izquierdo, I., et al.
Publicado: (2022)

Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention
por: Nunn, Andrew, et al.
Publicado: (2009)

Vaginal rings for delivery of HIV microbicides
por: Malcolm, R Karl, et al.
Publicado: (2012)

Pre-clinical evaluation of novel anti-tuberculosis molecules
por: Campos, Maria Martha
Publicado: (2014)

Derivation and validation of a prognostic prediction rule from clinical and stress CMR data characterizes cardiac prognostication in patients with suspected myocardial ischemia
por: Coelho-Filho, Otavio R, et al.
Publicado: (2011)

Efficacy of anti-ICOS agonist monoclonal antibodies in preclinical tumor models provides a rationale for clinical development as cancer immunotherapeutics
por: Harvey, Christopher, et al.
Publicado: (2015)

Microbicides Development Programme: Engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania
por: Vallely, Andrew, et al.
Publicado: (2009)

Vaginal deployment and tenofovir delivery by microbicide gels
por: Gao, Y., et al.
Publicado: (2015)

PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH
por: De Benedetti, F, et al.
Publicado: (2013)

PReS-FINAL-2194: Evidence-based clinical classification criteria for periodic fevers
por: Federici, S, et al.
Publicado: (2013)

Prediction of recurrent stroke and myocardial infarction after stroke: a systematic review of clinical prediction models
por: Thompson, Douglas, et al.
Publicado: (2013)

Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS
por: Gupta, Satish Kumar, et al.
Publicado: (2013)

Pre-clinical alterations in cardiovascular phenotypes and their associations with metabolic profiles among obese youths
por: Man, Elim, et al.
Publicado: (2015)

Diabetics without prior cardiovascular disease have diffuse interstitial fibrosis by CMR independent of clinical risk factors
por: Shah, Ravi, et al.
Publicado: (2012)

The clinical development of NRTIs — cautionary tales
por: Cooper, D
Publicado: (2010)

Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides
por: Tanphaichitr, Nongnuj, et al.
Publicado: (2016)

Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa
por: Nel, Annalene, et al.
Publicado: (2016)

Prediction of treatment benefit in high-dimensional cox models via gene signatures in randomized clinical trials
por: Ternès, Nils, et al.
Publicado: (2015)

Clinical trials in drug development: the Brazilian experience
por: de Morais, Odorico
Publicado: (2014)

PReS-FINAL-2175: Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring
por: Woillard, JB, et al.
Publicado: (2013)

Selective reporting in clinical trials - an examination of discrepancy rates in pre-specified and reported outcomes in articles submitted to the BMJ
por: Weston, Jennifer, et al.
Publicado: (2015)

Hypothesis-generating clinical genomics research and predictive medicine
por: Biesecker, Leslie
Publicado: (2012)

Clinical and kinematic predictors of foot orthoses efficacy in individuals with patellofemoral pain syndrome
por: Barton, Christian J, et al.
Publicado: (2011)

Safety and efficacy of varicella vaccination in children with JIA treated with biologic therapy
por: Toplak, Natasa, et al.
Publicado: (2014)

Developing the SCM workforce in Nigeria through contextualised pre-service education and continued professional development
por: Adekola, Adebayo, et al.
Publicado: (2014)

P15-22. Potential synergies between HIV vaccines, microbicides and pre-exposure prophylaxis
por: Sarazin, V, et al.
Publicado: (2009)

3 T cardiac magnetic resonance performs well as the primary scanner in a clinical setting: our initial experience at a tertiary care center
por: Rajaram, Mahadevan, et al.
Publicado: (2009)

KART, a knowledge authoring and refinement tool for clinical guidelines development
por: Pasche, E, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_o8micpl0ccmrkss5dsqf6tf02v